denkapparat Operations GmbH Takes $235,000 Position in Henry Schein, Inc. $HSIC

denkapparat Operations GmbH bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 3,222 shares of the company’s stock, valued at approximately $235,000.

Other institutional investors and hedge funds have also modified their holdings of the company. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Henry Schein in the 2nd quarter worth $43,000. Steph & Co. purchased a new position in Henry Schein during the second quarter valued at $44,000. CX Institutional grew its holdings in Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after purchasing an additional 337 shares during the period. TD Private Client Wealth LLC increased its position in Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock worth $49,000 after buying an additional 339 shares in the last quarter. Finally, Whittier Trust Co. increased its position in Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company’s stock worth $55,000 after buying an additional 700 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 0.5%

Shares of HSIC stock opened at $72.84 on Thursday. The company’s fifty day simple moving average is $66.58 and its two-hundred day simple moving average is $68.89. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The stock has a market cap of $8.58 billion, a P/E ratio of 23.50, a PEG ratio of 2.06 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.11. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.34 billion for the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of several analyst reports. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday, October 31st. Barrington Research set a $79.00 price objective on shares of Henry Schein and gave the company an “outperform” rating in a research report on Wednesday, November 5th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Finally, Wells Fargo & Company increased their price target on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus target price of $76.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.